Sign inCreate account

Report workspace tools

NCT02604524COMPLETEDanonymous

Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp

Sponsor

Source record

Daniel Chernavvsky, MD, CRC

Phase

Source record

NA

Modality

AI-normalized

medical device

Target

AI-normalized

Type 1 Diabetes Mellitus (T1DM)

Indication / condition

AI-normalized

Type 1 Diabetes Mellitus

Intervention

Source record

Closed-Loop Control, Sensor Augmented Pump Therapy

Source & freshness

Source record

NCT ID

NCT02604524

Original source

ClinicalTrials.gov

Source last updated

Sep 19, 2018

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT02604524

Title

Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp

Sponsor

Daniel Chernavvsky, MD, CRC

Status

COMPLETED

Phase

NA

Condition raw

Type 1 Diabetes Mellitus

Condition normalized

Type 1 Diabetes Mellitus

Modality raw

Type 1 Diabetes Mellitus

Modality normalized

medical device

Target raw

Type 1 Diabetes Mellitus (T1DM)

Target normalized

Type 1 Diabetes Mellitus (T1DM)

Interventions

Closed-Loop Control, Sensor Augmented Pump Therapy

Public preview

Source record

This study evaluated the effectiveness of a Closed-Loop Control (CLC) system, also known as an Artificial Pancreas, in managing blood glucose levels during extended exercise in youth with T1DM. Conducted at a ski camp, the trial aimed to demonstrate the superiority of CLC over traditional Sensor-Augmented Pump (SAP) therapy.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Reducing Risks and Improving Glucose Control During Extended Exercise in Youth With T1DM: The AP Ski Camp

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT02604524

Status

COMPLETED

Phase

NA

Sponsor

Daniel Chernavvsky, MD, CRC

Executive brief

Investment-Ready Snapshot

This study evaluated the effectiveness of a Closed-Loop Control (CLC) system, also known as an Artificial Pancreas, in managing blood glucose levels during extended exercise in youth with T1DM. Conducted at a ski camp, the trial aimed to demonstrate the superiority of CLC over traditional Sensor-Augmented Pump (SAP) therapy.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedSep 19, 2018
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT02604524

Indication

Type 1 Diabetes Mellitus

Modality

medical device

Target

Type 1 Diabetes Mellitus (T1DM)

Intervention

Closed-Loop Control, Sensor Augmented Pump Therapy

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.